| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.86e-08 | 5 | 189 | 4 | GO:0030156 | |
| GeneOntologyBiologicalProcess | cell junction organization | ROCK2 PPFIBP1 SPTB SLITRK4 ADGRB3 LAMA5 LAMC1 ZDHHC17 SLC1A1 SLITRK1 LRP8 SLC9A1 NPTXR CASKIN1 AGT CAPRIN2 DOCK7 LRP4 MACF1 TLN2 FLRT2 ADGRL3 SMAD3 TJP3 | 9.32e-06 | 974 | 188 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | ROCK2 SLITRK4 ADGRB3 SLITRK1 SLC9A1 CASKIN1 AGT LRP4 MACF1 FLRT2 ADGRL3 SMAD3 | 2.81e-05 | 309 | 188 | 12 | GO:1901888 |
| GeneOntologyCellularComponent | manchette | 1.10e-04 | 28 | 188 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.11e-04 | 33 | 188 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | laminin-10 complex | 2.40e-04 | 3 | 188 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 2.40e-04 | 3 | 188 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | interstitial matrix | 4.44e-04 | 17 | 188 | 3 | GO:0005614 | |
| Domain | - | PRAMEF7 KCTD9 MFHAS1 ECM2 SLITRK4 LRRC69 LRRC43 LRCH1 SLITRK1 LRIG2 LHCGR NLRP14 LRRC26 FLRT2 TBCE GP1BA NLRP13 | 2.21e-08 | 321 | 185 | 17 | 3.80.10.10 |
| Domain | L_dom-like | PRAMEF7 KCTD9 MFHAS1 ECM2 SLITRK4 LRRC69 LRRC43 LRCH1 SLITRK1 LRIG2 LHCGR NLRP14 LRRC26 FLRT2 TBCE GP1BA NLRP13 | 3.03e-08 | 328 | 185 | 17 | IPR032675 |
| Domain | Leu-rich_rpt | MFHAS1 ECM2 SLITRK4 LRRC69 LRRC43 LRCH1 SLITRK1 LRIG2 NLRP14 LRRC26 FLRT2 TBCE GP1BA NLRP13 | 5.48e-07 | 271 | 185 | 14 | IPR001611 |
| Domain | LRR_8 | MFHAS1 ECM2 SLITRK4 LRRC69 LRRC43 LRCH1 SLITRK1 LRIG2 LRRC26 FLRT2 GP1BA | 1.12e-06 | 171 | 185 | 11 | PF13855 |
| Domain | SH3_2 | 2.19e-06 | 86 | 185 | 8 | PF07653 | |
| Domain | SH3_2 | 2.19e-06 | 86 | 185 | 8 | IPR011511 | |
| Domain | PARP_ALPHA_HD | 3.80e-06 | 4 | 185 | 3 | PS51060 | |
| Domain | Poly(ADP-ribose)pol_reg_dom | 3.80e-06 | 4 | 185 | 3 | IPR004102 | |
| Domain | - | 3.80e-06 | 4 | 185 | 3 | 1.20.142.10 | |
| Domain | LRR_TYP | MFHAS1 ECM2 SLITRK4 LRRC69 LRCH1 SLITRK1 LRIG2 LRRC26 FLRT2 GP1BA | 1.10e-05 | 177 | 185 | 10 | SM00369 |
| Domain | Leu-rich_rpt_typical-subtyp | MFHAS1 ECM2 SLITRK4 LRRC69 LRCH1 SLITRK1 LRIG2 LRRC26 FLRT2 GP1BA | 1.10e-05 | 177 | 185 | 10 | IPR003591 |
| Domain | CH | 4.43e-05 | 65 | 185 | 6 | SM00033 | |
| Domain | SAM_1 | 5.73e-05 | 68 | 185 | 6 | PF00536 | |
| Domain | SAM_2 | 6.41e-05 | 43 | 185 | 5 | PF07647 | |
| Domain | CH | 6.75e-05 | 70 | 185 | 6 | PF00307 | |
| Domain | - | 7.31e-05 | 71 | 185 | 6 | 1.10.418.10 | |
| Domain | CH | 8.55e-05 | 73 | 185 | 6 | PS50021 | |
| Domain | Med12 | 9.76e-05 | 2 | 185 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 9.76e-05 | 2 | 185 | 2 | IPR021989 | |
| Domain | Med12-PQL | 9.76e-05 | 2 | 185 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 9.76e-05 | 2 | 185 | 2 | PF12145 | |
| Domain | Med12 | 9.76e-05 | 2 | 185 | 2 | SM01281 | |
| Domain | Mediator_Med12 | 9.76e-05 | 2 | 185 | 2 | IPR019035 | |
| Domain | Mediator_Med12_LCEWAV | 9.76e-05 | 2 | 185 | 2 | IPR021990 | |
| Domain | CH-domain | 9.95e-05 | 75 | 185 | 6 | IPR001715 | |
| Domain | GAIN_dom_N | 1.49e-04 | 11 | 185 | 3 | IPR032471 | |
| Domain | GAIN | 1.49e-04 | 11 | 185 | 3 | PF16489 | |
| Domain | LRR | 1.82e-04 | 201 | 185 | 9 | PS51450 | |
| Domain | SAM | 2.41e-04 | 88 | 185 | 6 | SM00454 | |
| Domain | Cys-rich_flank_reg_C | 2.72e-04 | 90 | 185 | 6 | IPR000483 | |
| Domain | LRRCT | 2.72e-04 | 90 | 185 | 6 | SM00082 | |
| Domain | WGR | 2.91e-04 | 3 | 185 | 2 | SM00773 | |
| Domain | PARP_reg | 2.91e-04 | 3 | 185 | 2 | PF02877 | |
| Domain | WGR | 2.91e-04 | 3 | 185 | 2 | PF05406 | |
| Domain | Protein_Kinase_C_mu-related | 2.91e-04 | 3 | 185 | 2 | IPR015727 | |
| Domain | - | 2.91e-04 | 3 | 185 | 2 | 2.20.140.10 | |
| Domain | SH3 | SH3TC2 SASH1 TSPOAP1 RIMBP3 CASKIN1 MACF1 RIMBP3C RIMBP3B TJP3 | 3.11e-04 | 216 | 185 | 9 | PS50002 |
| Domain | LRR_1 | 3.44e-04 | 219 | 185 | 9 | PF00560 | |
| Domain | SH3_domain | SH3TC2 SASH1 TSPOAP1 RIMBP3 CASKIN1 MACF1 RIMBP3C RIMBP3B TJP3 | 3.56e-04 | 220 | 185 | 9 | IPR001452 |
| Domain | SAM_DOMAIN | 3.65e-04 | 95 | 185 | 6 | PS50105 | |
| Domain | ARM-like | RIF1 XPO5 UNC45B NBEAL2 LTN1 HEATR9 NCAPD2 PRKDC MED12 ARMC6 | 3.72e-04 | 270 | 185 | 10 | IPR011989 |
| Domain | SAM | 4.08e-04 | 97 | 185 | 6 | IPR001660 | |
| Domain | LRRNT | 4.31e-04 | 98 | 185 | 6 | IPR000372 | |
| Domain | LRRNT | 4.31e-04 | 98 | 185 | 6 | SM00013 | |
| Domain | DEATH-like_dom | 4.55e-04 | 99 | 185 | 6 | IPR011029 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 5.87e-04 | 17 | 185 | 3 | IPR012317 | |
| Domain | PARP_CATALYTIC | 5.87e-04 | 17 | 185 | 3 | PS51059 | |
| Domain | PARP | 5.87e-04 | 17 | 185 | 3 | PF00644 | |
| Domain | - | 5.87e-04 | 17 | 185 | 3 | 3.90.228.10 | |
| Domain | - | 6.55e-04 | 106 | 185 | 6 | 1.10.150.50 | |
| Domain | UIM | 6.99e-04 | 18 | 185 | 3 | PF02809 | |
| Domain | Growth_fac_rcpt_ | 9.41e-04 | 156 | 185 | 7 | IPR009030 | |
| Domain | SLED | 9.57e-04 | 5 | 185 | 2 | IPR021987 | |
| Domain | SLED | 9.57e-04 | 5 | 185 | 2 | PF12140 | |
| Domain | SAM/pointed | 1.10e-03 | 117 | 185 | 6 | IPR013761 | |
| Domain | UIM | 1.12e-03 | 21 | 185 | 3 | SM00726 | |
| Domain | DAPIN | 1.28e-03 | 22 | 185 | 3 | PS50824 | |
| Domain | PYRIN | 1.28e-03 | 22 | 185 | 3 | SM01289 | |
| Domain | PYRIN | 1.28e-03 | 22 | 185 | 3 | PF02758 | |
| Domain | DAPIN | 1.28e-03 | 22 | 185 | 3 | IPR004020 | |
| Domain | - | 1.43e-03 | 6 | 185 | 2 | 3.90.1290.10 | |
| Domain | SH3 | 1.43e-03 | 216 | 185 | 8 | SM00326 | |
| Domain | Spectrin | 1.46e-03 | 23 | 185 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.46e-03 | 23 | 185 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.46e-03 | 23 | 185 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.46e-03 | 23 | 185 | 3 | IPR001589 | |
| Domain | UIM | 1.66e-03 | 24 | 185 | 3 | PS50330 | |
| Domain | WGR_domain | 1.66e-03 | 24 | 185 | 3 | IPR008893 | |
| Domain | - | 1.70e-03 | 222 | 185 | 8 | 1.25.10.10 | |
| Domain | UIM_dom | 1.87e-03 | 25 | 185 | 3 | IPR003903 | |
| Domain | HormR | 1.87e-03 | 25 | 185 | 3 | SM00008 | |
| Domain | Plectin | 1.98e-03 | 7 | 185 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.98e-03 | 7 | 185 | 2 | IPR001101 | |
| Domain | PLEC | 1.98e-03 | 7 | 185 | 2 | SM00250 | |
| Domain | ARM-type_fold | 2.09e-03 | 339 | 185 | 10 | IPR016024 | |
| Domain | - | 2.10e-03 | 26 | 185 | 3 | 1.25.40.90 | |
| Domain | THIOL_PROTEASE_CYS | 2.10e-03 | 26 | 185 | 3 | PS00139 | |
| Domain | TPR-like_helical_dom | 2.30e-03 | 233 | 185 | 8 | IPR011990 | |
| Domain | - | 2.32e-03 | 93 | 185 | 5 | 1.10.533.10 | |
| Domain | THIOL_PROTEASE_ASN | 2.35e-03 | 27 | 185 | 3 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 2.35e-03 | 27 | 185 | 3 | PS00639 | |
| Domain | C1_1 | 2.44e-03 | 57 | 185 | 4 | PF00130 | |
| Domain | HRM | 2.61e-03 | 28 | 185 | 3 | PF02793 | |
| Domain | LAMININ_IVA | 2.63e-03 | 8 | 185 | 2 | PS51115 | |
| Domain | Laminin_B | 2.63e-03 | 8 | 185 | 2 | PF00052 | |
| Domain | LamB | 2.63e-03 | 8 | 185 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.63e-03 | 8 | 185 | 2 | IPR000034 | |
| Domain | ENTH_VHS | 2.89e-03 | 29 | 185 | 3 | IPR008942 | |
| Domain | Spectrin_repeat | 2.89e-03 | 29 | 185 | 3 | IPR002017 | |
| Domain | EGF_LAM_2 | 3.19e-03 | 30 | 185 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 3.19e-03 | 30 | 185 | 3 | PS01248 | |
| Domain | MBT | 3.36e-03 | 9 | 185 | 2 | SM00561 | |
| Domain | MBT | 3.36e-03 | 9 | 185 | 2 | PS51079 | |
| Domain | ZF_DAG_PE_1 | 3.73e-03 | 64 | 185 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.73e-03 | 64 | 185 | 4 | PS50081 | |
| Domain | SPEC | 3.84e-03 | 32 | 185 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.84e-03 | 32 | 185 | 3 | IPR018159 | |
| Domain | TPR-contain_dom | 3.84e-03 | 150 | 185 | 6 | IPR013026 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRKD2 EPPK1 MFHAS1 HECTD4 LAMA5 FYCO1 SMG5 ATP13A2 BIRC6 PLEKHG5 MADD CCDC142 JAG2 CCDC88C ZGPAT CELSR2 SYNJ1 SLC45A3 INF2 NBEAL2 CASKIN1 NCAPD2 NAV2 LRP4 PDCD11 TLN2 PRKDC MED12 RIC1 RAI1 TJP3 | 1.04e-13 | 1105 | 192 | 31 | 35748872 |
| Pubmed | ROCK2 SIN3B SH3TC2 PPFIBP1 ZFC3H1 BIRC6 SLITRK1 EPN2 LRIG2 CCDC88C PARP4 ZNF526 VPS13D SUN2 DNAH17 LTN1 MACF1 FLRT2 MEX3B MED12 RIC1 | 5.98e-13 | 493 | 192 | 21 | 15368895 | |
| Pubmed | GGA2 SASH1 HECTD4 ADGRB3 LAMA5 SMG5 LRCH1 PLEKHG5 TECPR2 NBEAL2 CASKIN1 CAPRIN2 NCAPD2 MED12L ANKIB1 NAV2 LRP4 PDCD11 IFT80 RAI1 | 1.88e-11 | 529 | 192 | 20 | 14621295 | |
| Pubmed | LNX2 PROSER1 CCDC168 COG3 SLITRK1 PARP4 INTS6 MTRF1 MED4 TMTC4 GPC5 | 3.13e-09 | 170 | 192 | 11 | 15057823 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 4.48e-09 | 5 | 192 | 4 | 17855024 | |
| Pubmed | ROCK2 KCTD9 SIN3B SYT3 IQGAP2 HECTD4 ADGRB3 FYCO1 STRIP1 LRIG2 CCDC88C CELSR2 SYNJ1 RABEP1 CASKIN1 SPHKAP DOCK7 SMARCC1 MACF1 TLN2 RAI1 | 1.01e-07 | 963 | 192 | 21 | 28671696 | |
| Pubmed | 5.57e-07 | 225 | 192 | 10 | 12168954 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 6.60e-07 | 4 | 192 | 3 | 19091768 | |
| Pubmed | SIN3B NET1 SCAF8 PPFIBP1 PARP2 LAMA5 ABCB6 ZFC3H1 STRIP1 EPN2 ZGPAT RIF1 INTS6 SLC9A1 MED4 TBC1D10A SUN2 LTN1 NCAPD2 PDCD11 MACF1 MED12 RBFA CDK7 | 2.99e-06 | 1497 | 192 | 24 | 31527615 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 29187380 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 5.21e-06 | 79 | 192 | 6 | 18757743 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 1.02e-05 | 52 | 192 | 5 | 24613359 | |
| Pubmed | EPPK1 BIRC6 RIF1 XPO5 GLYR1 NCAPD2 DOCK7 SMARCC1 PDCD11 MACF1 PRKDC NNT MED12 RAI1 | 1.80e-05 | 653 | 192 | 14 | 22586326 | |
| Pubmed | TSPOAP1 SCAF8 ZDHHC17 MADD STRIP1 XPO5 SPHKAP DOCK7 MACF1 ST18 ADGRL3 | 1.82e-05 | 407 | 192 | 11 | 12693553 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ROCK2 IQGAP2 PPFIBP1 SLITRK4 PAM16 EPN2 LRP8 SLC9A1 CELSR2 TBC1D10A NBEAL2 DOCK7 NAV2 | 1.87e-05 | 569 | 192 | 13 | 30639242 |
| Pubmed | TSPOAP1 ADGRB3 DGKG TACC2 BIRC6 VPS37B MADD CELSR2 SYNJ1 RABEP1 GLYR1 CASKIN1 SPHKAP DOCK7 MACF1 TLN2 TAB1 ADGRL3 ARMC6 | 2.00e-05 | 1139 | 192 | 19 | 36417873 | |
| Pubmed | 2.15e-05 | 101 | 192 | 6 | 9872452 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.21e-05 | 208 | 192 | 8 | 33230847 | |
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | SFMBT1 RIMBP3 IFIH1 ZGPAT SLC11A1 CEP250 USP4 TAB1 USF1 SMAD3 | 2.26e-05 | 342 | 192 | 10 | 23128233 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ROCK2 EPPK1 SCAF8 RIF1 PARP4 INTS6 XPO5 NCAPD2 MED12L MACF1 TLN2 PRKDC CDK3 | 2.36e-05 | 582 | 192 | 13 | 20467437 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SASH1 NET1 PPFIBP1 LAMC1 MADD EPN2 CCDC88C VPS13D SYNJ1 RABEP1 DOCK7 NAV2 MACF1 TAB1 MEX3B CDK3 | 2.60e-05 | 861 | 192 | 16 | 36931259 |
| Pubmed | PPFIBP1 FYCO1 COG3 SLC1A1 MADD LRP8 PRKD3 LRIG2 VPS13D INF2 SUN2 RIC1 | 2.64e-05 | 504 | 192 | 12 | 34432599 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 7260241 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 30841931 | ||
| Pubmed | Identification of a novel gene (ADPRTL1) encoding a potential Poly(ADP-ribosyl)transferase protein. | 3.03e-05 | 2 | 192 | 2 | 10644454 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 10329013 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 30379609 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 15070709 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 29930006 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 37044359 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 28753627 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 18802024 | ||
| Pubmed | Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration. | 3.03e-05 | 2 | 192 | 2 | 24840177 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 25728924 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 10601104 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 29361132 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 23045614 | ||
| Pubmed | Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes. | 3.03e-05 | 2 | 192 | 2 | 25802335 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 23393329 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 16963053 | ||
| Pubmed | Smad3 mediates ANG II-induced hypertensive kidney disease in mice. | 3.03e-05 | 2 | 192 | 2 | 22237801 | |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 3.34e-05 | 161 | 192 | 7 | 32572027 | |
| Pubmed | ANKRD13B PARP2 LAMC1 BIRC6 VPS37B MADD EPN2 RIF1 RABEP1 ANKIB1 COPS7B USP4 TAB1 | 3.46e-05 | 604 | 192 | 13 | 38803224 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 5.76e-05 | 14 | 192 | 3 | 17662146 | |
| Pubmed | 7.18e-05 | 15 | 192 | 3 | 9264260 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SIN3B SYT3 SCAF8 ADGRB3 SMG5 MADD INTS6 SYNJ1 NPTXR CASKIN1 TLN2 | 7.35e-05 | 475 | 192 | 11 | 31040226 |
| Pubmed | ANKRD13B HECTD4 LAMA5 LAMC1 EPN2 USP6 RABEP1 MACF1 USP4 TAB1 CDK7 | 8.21e-05 | 481 | 192 | 11 | 28190767 | |
| Pubmed | 8.48e-05 | 129 | 192 | 6 | 23022380 | ||
| Pubmed | Family-wide analysis of poly(ADP-ribose) polymerase activity. | 8.80e-05 | 16 | 192 | 3 | 25043379 | |
| Pubmed | 8.85e-05 | 130 | 192 | 6 | 12421765 | ||
| Pubmed | Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. | 9.06e-05 | 3 | 192 | 2 | 26253275 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 27662904 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 14636058 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 18489431 | ||
| Pubmed | Immune-evasive human islet-like organoids ameliorate diabetes. | 9.06e-05 | 3 | 192 | 2 | 32814902 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 29884876 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 17096706 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 34066057 | ||
| Pubmed | Super-complexes of adhesion GPCRs and neural guidance receptors. | 9.06e-05 | 3 | 192 | 2 | 27091502 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 22842919 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 21311558 | ||
| Pubmed | Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart. | 9.06e-05 | 3 | 192 | 2 | 38419169 | |
| Pubmed | Expression of the protein kinase D (PKD) family during mouse embryogenesis. | 9.06e-05 | 3 | 192 | 2 | 16377259 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 32747433 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 26426580 | ||
| Pubmed | A clinical and experimental study of adult hereditary spherocytosis in the Chinese population. | 9.06e-05 | 3 | 192 | 2 | 32133777 | |
| Pubmed | Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs. | 9.06e-05 | 3 | 192 | 2 | 25800440 | |
| Pubmed | Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. | 9.06e-05 | 3 | 192 | 2 | 15699465 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 11133776 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 10481268 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 22547438 | ||
| Pubmed | Progress and outlook in studying the substrate specificities of PARPs and related enzymes. | 9.06e-05 | 3 | 192 | 2 | 32785980 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 20547485 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 18341998 | ||
| Pubmed | Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes. | 1.06e-04 | 17 | 192 | 3 | 34879283 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SLITRK4 SLITRK1 IFIH1 VPS13D NBEAL2 NCAPD2 COPS7B NAV2 MED12 RIC1 RAI1 | 1.09e-04 | 497 | 192 | 11 | 36774506 |
| Pubmed | 1.15e-04 | 263 | 192 | 8 | 12665801 | ||
| Pubmed | SFMBT1 SIN3B LAMC1 BIRC6 SFMBT2 SYNJ1 RABEP1 DOCK7 KAT14 MED12 | 1.20e-04 | 418 | 192 | 10 | 34709266 | |
| Pubmed | ROCK2 NUP50 TACC2 ZXDA STRIP1 PRKD3 RIF1 NCAPD2 NAV2 TLN2 CDK3 | 1.22e-04 | 503 | 192 | 11 | 16964243 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.27e-04 | 18 | 192 | 3 | 12119179 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.39e-04 | 202 | 192 | 7 | 33005030 | |
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 1.81e-04 | 4 | 192 | 2 | 12820173 | |
| Pubmed | Construction and characterization of a normalized cDNA library. | 1.81e-04 | 4 | 192 | 2 | 7937745 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 379653 | ||
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 33620149 | ||
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 1.81e-04 | 4 | 192 | 2 | 37224017 | |
| Pubmed | Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain. | 1.81e-04 | 4 | 192 | 2 | 35121993 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 25852083 | ||
| Pubmed | A tight control of Rif1 by Oct4 and Smad3 is critical for mouse embryonic stem cell stability. | 1.81e-04 | 4 | 192 | 2 | 25569105 | |
| Pubmed | Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. | 1.81e-04 | 4 | 192 | 2 | 14743217 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 12032072 | ||
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 9299121 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 1.81e-04 | 4 | 192 | 2 | 35008625 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 10772878 | ||
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 15967115 | ||
| Pubmed | Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1. | 1.81e-04 | 4 | 192 | 2 | 27670070 | |
| Pubmed | Analysis of the interaction between GGA1 GAT domain and Rabaptin-5. | 1.81e-04 | 4 | 192 | 2 | 16473621 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 21812955 | ||
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 10950304 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PRAMEF7 LNX2 DIPK1A SLITRK4 CDH23 ABCB6 PAM16 TBC1D10A NBEAL2 PGAP2 CEP250 DNAH17 CAPRIN2 USP4 GPC5 IFT80 ST18 KAT14 | 1.96e-04 | 1242 | 192 | 18 | 30973865 |
| Interaction | TOP3B interactions | PRKD2 EPPK1 MFHAS1 SPTB HECTD4 LAMA5 FYCO1 SMG5 ATP13A2 BIRC6 PLEKHG5 MADD CCDC142 JAG2 CCDC88C ZGPAT CELSR2 SYNJ1 XPO5 SLC45A3 INF2 NBEAL2 CASKIN1 NCAPD2 NAV2 LRP4 PDCD11 TLN2 PRKDC MEX3B MED12 RIC1 RAI1 TJP3 | 4.94e-07 | 1470 | 185 | 34 | int:TOP3B |
| GeneFamily | Sterile alpha motif domain containing | 4.12e-05 | 88 | 130 | 6 | 760 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.29e-04 | 17 | 130 | 3 | 684 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 7.44e-04 | 25 | 130 | 3 | 994 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.05e-03 | 7 | 130 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.40e-03 | 8 | 130 | 2 | 939 | |
| GeneFamily | Cyclins|Mediator complex | 1.69e-03 | 33 | 130 | 3 | 1061 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.79e-03 | 9 | 130 | 2 | 1263 | |
| GeneFamily | Laminin subunits | 3.23e-03 | 12 | 130 | 2 | 626 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.77e-03 | 206 | 130 | 6 | 682 | |
| GeneFamily | Low density lipoprotein receptors | 3.80e-03 | 13 | 130 | 2 | 634 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-07 | 155 | 189 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 183 | 189 | 8 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-06 | 184 | 189 | 8 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.40e-06 | 187 | 189 | 8 | d3563bb087e476baea5b59389e4d34d0ff98cac5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 191 | 189 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.64e-06 | 191 | 189 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-06 | 151 | 189 | 7 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-06 | 161 | 189 | 7 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-06 | 161 | 189 | 7 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-06 | 161 | 189 | 7 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-06 | 162 | 189 | 7 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 174 | 189 | 7 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 175 | 189 | 7 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 175 | 189 | 7 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.08e-05 | 177 | 189 | 7 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.17e-05 | 179 | 189 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 182 | 189 | 7 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 182 | 189 | 7 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 182 | 189 | 7 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 183 | 189 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.35e-05 | 183 | 189 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.39e-05 | 184 | 189 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 185 | 189 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.44e-05 | 185 | 189 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.55e-05 | 187 | 189 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.71e-05 | 190 | 189 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 190 | 189 | 7 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-05 | 190 | 189 | 7 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 190 | 189 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-05 | 190 | 189 | 7 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-05 | 190 | 189 | 7 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.77e-05 | 191 | 189 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 191 | 189 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-05 | 192 | 189 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-05 | 192 | 189 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-05 | 193 | 189 | 7 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-05 | 193 | 189 | 7 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 194 | 189 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 194 | 189 | 7 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.96e-05 | 194 | 189 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.03e-05 | 195 | 189 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 195 | 189 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.03e-05 | 195 | 189 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.03e-05 | 195 | 189 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.03e-05 | 195 | 189 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.03e-05 | 195 | 189 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 195 | 189 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.03e-05 | 195 | 189 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 196 | 189 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.09e-05 | 196 | 189 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 197 | 189 | 7 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-05 | 197 | 189 | 7 | 467e7cbf511d3bcc701923603032aaf0bba2736d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-05 | 198 | 189 | 7 | 447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 198 | 189 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 2.31e-05 | 199 | 189 | 7 | d65847ceb68a560798df3f73e6f838e7c3e38a1c | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.38e-05 | 200 | 189 | 7 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.38e-05 | 200 | 189 | 7 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.38e-05 | 200 | 189 | 7 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 200 | 189 | 7 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 142 | 189 | 6 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.23e-05 | 149 | 189 | 6 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-05 | 165 | 189 | 6 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-05 | 165 | 189 | 6 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-05 | 165 | 189 | 6 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 165 | 189 | 6 | d2ab667ff53f538b12ee4e07ea4b4d118600a228 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.46e-05 | 165 | 189 | 6 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-05 | 165 | 189 | 6 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.46e-05 | 165 | 189 | 6 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 166 | 189 | 6 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 166 | 189 | 6 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 166 | 189 | 6 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 166 | 189 | 6 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.24e-05 | 168 | 189 | 6 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 8.52e-05 | 169 | 189 | 6 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.80e-05 | 170 | 189 | 6 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | COVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type | 9.09e-05 | 171 | 189 | 6 | 0e8d63c8fbccdda4f1ef00de00667a50464b104b | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-05 | 171 | 189 | 6 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.38e-05 | 172 | 189 | 6 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 174 | 189 | 6 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-04 | 174 | 189 | 6 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-04 | 174 | 189 | 6 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 174 | 189 | 6 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 174 | 189 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 189 | 6 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 1.03e-04 | 175 | 189 | 6 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 1.03e-04 | 175 | 189 | 6 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.03e-04 | 175 | 189 | 6 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 189 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.06e-04 | 176 | 189 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 176 | 189 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 177 | 189 | 6 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 177 | 189 | 6 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-04 | 179 | 189 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 179 | 189 | 6 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 179 | 189 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 181 | 189 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.24e-04 | 181 | 189 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 182 | 189 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.28e-04 | 182 | 189 | 6 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 182 | 189 | 6 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.61e-06 | 197 | 187 | 10 | 5340_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 1223_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 4537_UP | |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 2377_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 7423_DN | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 3.52e-05 | 195 | 187 | 9 | 4533_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A | 3.52e-05 | 195 | 187 | 9 | 1214_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.67e-05 | 196 | 187 | 9 | 2090_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.67e-05 | 196 | 187 | 9 | 7429_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 1830_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 3.97e-05 | 198 | 187 | 9 | 407_DN | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 5515_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; PC3; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 5813_DN | |
| Drug | arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A | 3.97e-05 | 198 | 187 | 9 | 594_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 3908_UP | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.29e-05 | 200 | 187 | 9 | 5474_DN | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 4.29e-05 | 200 | 187 | 9 | 7229_DN | |
| Disease | Left Ventricle Remodeling | 7.07e-06 | 21 | 178 | 4 | C0600520 | |
| Disease | Ventricular Remodeling | 7.07e-06 | 21 | 178 | 4 | C0600519 | |
| Disease | dyschromatosis universalis hereditaria (is_implicated_in) | 3.62e-05 | 2 | 178 | 2 | DOID:0060304 (is_implicated_in) | |
| Disease | cortical surface area measurement | ROCK2 PRKD2 SAMD9 IQGAP2 MFHAS1 PPFIBP1 LRRC69 LAMC1 LRCH1 ATP13A2 STRIP1 LRP8 JAG2 CCDC88C TIGD2 EDEM2 EXOC6B NAV2 MACF1 TLN2 SPAG17 | 6.60e-05 | 1345 | 178 | 21 | EFO_0010736 |
| Disease | cortical thickness | ANKRD13B PPFIBP1 LAMC1 TACC2 LRCH1 ATP13A2 LRP8 JAG2 VPS13D XPO5 COL21A1 GLYR1 DOCK7 NAV2 LRP4 MACF1 ST18 MIEF2 | 1.46e-04 | 1113 | 178 | 18 | EFO_0004840 |
| Disease | Elliptocytosis found | 2.15e-04 | 4 | 178 | 2 | C0427480 | |
| Disease | Hereditary elliptocytosis | 2.15e-04 | 4 | 178 | 2 | cv:C0013902 | |
| Disease | laminin measurement | 2.15e-04 | 4 | 178 | 2 | EFO_0020528 | |
| Disease | Malignant neoplasm of breast | SYT3 NET1 NUDT2 DGKG ABCB6 TACC2 COG3 JAG2 LHCGR RIF1 NLRP14 TMTC4 UNC45B HEATR9 MACF1 EXOC3L1 MED12 | 2.89e-04 | 1074 | 178 | 17 | C0006142 |
| Disease | hereditary spherocytosis (is_implicated_in) | 3.58e-04 | 5 | 178 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Aneurysm, Dissecting | 3.58e-04 | 5 | 178 | 2 | C0002949 | |
| Disease | Hereditary spherocytosis | 3.58e-04 | 5 | 178 | 2 | cv:C0037889 | |
| Disease | Dissection of aorta | 3.58e-04 | 5 | 178 | 2 | C0340643 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 3.58e-04 | 5 | 178 | 2 | C0221409 | |
| Disease | Dissection, Blood Vessel | 3.58e-04 | 5 | 178 | 2 | C4277533 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 4.50e-04 | 59 | 178 | 4 | EFO_0022248 | |
| Disease | Elliptocytosis, Hereditary | 5.34e-04 | 6 | 178 | 2 | C0013902 | |
| Disease | hydrocephalus (is_implicated_in) | 5.34e-04 | 6 | 178 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | corneal dystrophy (is_implicated_in) | 5.34e-04 | 6 | 178 | 2 | DOID:2566 (is_implicated_in) | |
| Disease | Nephrotic Syndrome | 5.68e-04 | 27 | 178 | 3 | C0027726 | |
| Disease | Polysyndactyly | 7.45e-04 | 7 | 178 | 2 | C0265553 | |
| Disease | Aortic Aneurysm | 7.45e-04 | 7 | 178 | 2 | C0003486 | |
| Disease | Hereditary spherocytosis | 9.89e-04 | 8 | 178 | 2 | C0037889 | |
| Disease | Syndactyly | 9.89e-04 | 8 | 178 | 2 | C0039075 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.15e-03 | 264 | 178 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | aspartate aminotransferase measurement | PRKD2 WWC3 IQGAP2 MFHAS1 HECTD4 FYCO1 BIRC6 MADD ZGPAT EDEM2 IFT80 PDE7B ARMC6 TJP3 | 1.23e-03 | 904 | 178 | 14 | EFO_0004736 |
| Disease | breast carcinoma | PRKD2 SH3TC2 CTSF ESRRG LAMC1 TACC2 MADD CCDC88C NPTXR ANKIB1 GPC5 SPAG17 HSF2 NNT SMAD3 | 1.36e-03 | 1019 | 178 | 15 | EFO_0000305 |
| Disease | cholesterol in very small VLDL measurement | 1.81e-03 | 40 | 178 | 3 | EFO_0022231 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.85e-03 | 86 | 178 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | executive function measurement | 2.11e-03 | 376 | 178 | 8 | EFO_0009332 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.21e-03 | 150 | 178 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | diabetic nephropathy | 2.21e-03 | 150 | 178 | 5 | EFO_0000401 | |
| Disease | free cholesterol to total lipids in IDL percentage | 2.23e-03 | 43 | 178 | 3 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 2.23e-03 | 43 | 178 | 3 | EFO_0022254 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.30e-03 | 12 | 178 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.30e-03 | 12 | 178 | 2 | EFO_0008141 | |
| Disease | survival time, Sepsis | 2.30e-03 | 12 | 178 | 2 | EFO_0000714, HP_0100806 | |
| Disease | cholesterol in medium VLDL measurement | 2.38e-03 | 44 | 178 | 3 | EFO_0022225 | |
| Disease | total lipids in very small VLDL measurement | 2.54e-03 | 45 | 178 | 3 | EFO_0022156 | |
| Disease | Craniofacial Abnormalities | 2.62e-03 | 156 | 178 | 5 | C0376634 | |
| Disease | Anemia, Hemolytic, Acquired | 2.70e-03 | 13 | 178 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 2.70e-03 | 13 | 178 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 2.70e-03 | 13 | 178 | 2 | C0002889 | |
| Disease | Neurodegeneration with brain iron accumulation | 2.70e-03 | 13 | 178 | 2 | cv:C2931845 | |
| Disease | Microangiopathic hemolytic anemia | 2.70e-03 | 13 | 178 | 2 | C0221021 | |
| Disease | free cholesterol in small VLDL measurement | 2.88e-03 | 47 | 178 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 2.88e-03 | 47 | 178 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 2.88e-03 | 47 | 178 | 3 | EFO_0022269 | |
| Disease | creatinine measurement | CAPN12 SFMBT1 PRKD2 SCAF8 LAMA5 ETNPPL BIRC6 JAG2 MED4 CELSR2 CYP26C1 EDEM2 DOCK7 SMAD3 | 2.95e-03 | 995 | 178 | 14 | EFO_0004518 |
| Disease | platelet measurement | 3.12e-03 | 315 | 178 | 7 | EFO_0005036 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.24e-03 | 49 | 178 | 3 | EFO_0022256 | |
| Disease | lymphocyte count | ROCK2 KCTD9 SH3TC2 EPPK1 IQGAP2 SPTB HECTD4 CDH23 SLC4A1 IFIH1 SLC45A3 RABEP1 DNAH17 MED12L USP4 HSF2 MEX3B RAI1 | 3.36e-03 | 1464 | 178 | 18 | EFO_0004587 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.39e-03 | 239 | 178 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | phospholipids in very small VLDL measurement | 3.63e-03 | 51 | 178 | 3 | EFO_0022300 | |
| Disease | cholesterol to total lipids in small HDL percentage | 3.63e-03 | 51 | 178 | 3 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 3.63e-03 | 51 | 178 | 3 | EFO_0022242 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.67e-03 | 243 | 178 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | phospholipids in IDL measurement | 3.84e-03 | 52 | 178 | 3 | EFO_0022164 | |
| Disease | cholesterol in small VLDL measurement | 4.05e-03 | 53 | 178 | 3 | EFO_0022228 | |
| Disease | response to antineoplastic agent, response to antimicrotubule agent | 4.11e-03 | 16 | 178 | 2 | EFO_0005260, GO_0097327 | |
| Disease | migraine disorder, fasting blood insulin measurement | 4.11e-03 | 16 | 178 | 2 | EFO_0004466, MONDO_0005277 | |
| Disease | neutrophil count | TSPOAP1 DIPK1A HECTD4 CDH23 DGKG PCDHA5 TENT5B JAG2 LRIG2 IFIH1 ZGPAT SLC9A1 RABEP1 NBEAL2 LRP4 TLN2 PRKDC | 4.33e-03 | 1382 | 178 | 17 | EFO_0004833 |
| Disease | cholesterol to total lipids in large HDL percentage | 4.50e-03 | 55 | 178 | 3 | EFO_0022234 | |
| Disease | copine-1 measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0008102 | |
| Disease | C-X-C motif chemokine 16 measurement | 5.20e-03 | 18 | 178 | 2 | EFO_0010911 | |
| Disease | Nuclear non-senile cataract | 5.20e-03 | 18 | 178 | 2 | C1112705 | |
| Disease | Nuclear cataract | 5.20e-03 | 18 | 178 | 2 | C0392557 | |
| Disease | urate measurement, spine bone mineral density | 5.22e-03 | 58 | 178 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 5.22e-03 | 58 | 178 | 3 | EFO_0022338 | |
| Disease | neuroimaging measurement | SAMD9 LAMC1 TACC2 LRCH1 ATP13A2 LRP8 JAG2 CCDC88C SYNJ1 PROSER3 NAV2 MACF1 TLN2 RAI1 | 5.53e-03 | 1069 | 178 | 14 | EFO_0004346 |
| Disease | apolipoprotein A 1 measurement | DGKG LAMC1 LRRC43 MADD LHCGR CELSR2 PCSK6 CYP26C1 DOCK7 SMARCC1 MACF1 NNT | 5.54e-03 | 848 | 178 | 12 | EFO_0004614 |
| Disease | von Willebrand factor measurement, coronary artery disease | 5.76e-03 | 118 | 178 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 5.78e-03 | 19 | 178 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 5.78e-03 | 19 | 178 | 2 | DOID:10003 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDSLVSNVNIELLNA | 156 | Q15582 | |
| AQLQQLFLSLGLEEN | 626 | Q86VI1 | |
| NSGVLESLLNLLDNL | 2131 | Q9NR09 | |
| LLELANVQELAEGAN | 46 | Q9H9Q2 | |
| LLIVNNTGSNIEDLV | 826 | Q8WWZ4 | |
| DLVATLSQLGLQELF | 346 | P08697 | |
| LDLQETSLAGVANQL | 121 | P02730 | |
| GIDDQSLILLNNVVL | 206 | O60242 | |
| FLTGVLDNLVEQNVL | 21 | P49662 | |
| LIQEQEQELVGALAA | 36 | P30838 | |
| DQGLLLQSLNALSVL | 151 | Q6NXE6 | |
| DLLDAQGLQLLVATL | 171 | Q6NXE6 | |
| DQLVGLLDVQLRNLT | 596 | Q9HAR2 | |
| LLIENGFDVNTLLAD | 326 | Q8WXK1 | |
| LLNQTQNLVIGLGLL | 496 | Q9NP58 | |
| TLSAILGVDAQLQLL | 71 | Q8WXA8 | |
| ILLAIQLSLQESGLA | 856 | Q9P2G1 | |
| SIFQQLDGALLCLLQ | 636 | Q17RM4 | |
| IDATQLQGLLNQELL | 516 | Q6MZZ7 | |
| LAQLVFLLGINQADL | 2421 | Q9HCU4 | |
| NNAIEFLLLQASDGI | 21 | P50583 | |
| IQVLALDADIGNNSL | 2866 | Q9H251 | |
| QNLTSLERLIVDGNL | 201 | O43155 | |
| LAVLDIIENEDLQGN | 321 | Q8TBG4 | |
| LLVAQGRADSQAQLL | 181 | P01019 | |
| RADTNLGNILLNVLI | 396 | Q9UKX7 | |
| GNAALAELDQLLAVA | 186 | Q8N0V3 | |
| ALAQEDLASEILGLQ | 601 | Q7Z5J4 | |
| EFILLGLTQSQDIQL | 11 | A0A096LPK9 | |
| SEILLEELQQGLSQA | 606 | Q15276 | |
| DASGLIAEQLLQQAA | 651 | A6NNM3 | |
| DASGLIAEQLLQQAA | 651 | A6NJZ7 | |
| AGSVLVELSQLQLLQ | 1036 | O95153 | |
| LVRNLGEQALLLAQS | 836 | Q4ADV7 | |
| FDLLNLNRLVTGIDN | 96 | Q9UL03 | |
| LLSEVALGQCNELLE | 486 | Q9UGN5 | |
| LLVLADIELAQALQA | 286 | Q9Y6F1 | |
| DSEELNIILQGNIIL | 66 | Q68G75 | |
| QLTTLNLGNNLLEEV | 61 | Q6ZNQ3 | |
| VLLALQALQLAGALD | 6 | Q7Z304 | |
| LLSIQEDLLENVLGC | 1441 | O94822 | |
| DAILIIQGVLSDINL | 341 | Q7Z628 | |
| DLLQFAIQQSLLEAG | 506 | Q86YJ7 | |
| NFGLNVVENLALLVL | 116 | Q9UHJ9 | |
| AALNGNTELISLLLE | 56 | Q8WXD9 | |
| QLIVNDGINLLGVLE | 156 | Q7L273 | |
| VSLENAVLDQLLNLG | 266 | Q9NPJ1 | |
| AVLDQLLNLGRQLIS | 271 | Q9NPJ1 | |
| ANAFDNLLNLSEILI | 91 | P22888 | |
| VLDQLANLNGRDLSI | 1416 | Q8WXG6 | |
| LNINGLIDFAIQLLN | 841 | Q86YW9 | |
| ISASIGNAQLLLQID | 191 | Q99456 | |
| LTGLEELVLQGNQIA | 341 | Q9Y4C4 | |
| LQLALQALGSEEETN | 701 | Q86W92 | |
| LQALNLGIEVINTTD | 226 | P78333 | |
| QTSGEEELQLQLALA | 271 | O95208 | |
| ELAAQLALSQAQLEV | 766 | Q9BQS8 | |
| ELQLSALRNVNGELL | 31 | Q9Y219 | |
| QASLNAGLDLRLAVQ | 36 | Q96BX8 | |
| GDVLLNINGIDLTNL | 516 | Q8N448 | |
| SLDTLQNVSLQLEGL | 681 | Q9P219 | |
| NQDLSQLELLLGGLL | 476 | Q9NRD8 | |
| ALDTLLILGNVSEFQ | 81 | Q9BV94 | |
| VAGIIALALEANSQL | 426 | P29122 | |
| EFILLGLTQSQDIQL | 11 | Q8NGD1 | |
| EFILLGLTQSQDIQL | 11 | Q8N0Y3 | |
| EFILLGLTQSQDAQL | 11 | Q8IXE1 | |
| IEQQLGSLILATDIN | 271 | Q9NP56 | |
| LDQVVNAALLLVDGI | 511 | Q9H8E8 | |
| QTLLDILNQGQLASI | 466 | Q49A26 | |
| QLLLNAQGQVIATLA | 46 | Q14863 | |
| ISAGAIDLINNLLQV | 776 | Q9BZL6 | |
| ISGEAIDLINNLLQV | 801 | O94806 | |
| AEALELQDSALNGQI | 486 | Q9Y2L9 | |
| ISGLIDFAIQLLNEL | 886 | Q93074 | |
| LRDLSGLNDLLNVLQ | 421 | P49279 | |
| DALAEILQANDLLTQ | 291 | Q9UJY4 | |
| QLLLEAEVRQLTLGA | 681 | Q9Y2D4 | |
| GQLALNLSSIILDVN | 2496 | O15230 | |
| LLQAGEENQVLELLI | 56 | Q9NPJ6 | |
| EATQLASEQLQALLL | 236 | Q9UKK3 | |
| QLLEVEDLSLSLLQG | 51 | Q86WC4 | |
| LTGTVQLLINVLDAN | 221 | Q9Y5H7 | |
| AGNDALQDVLSLLND | 1376 | Q9Y4D8 | |
| DQLEGQLLAQVLALE | 236 | O95502 | |
| VQFLEQSGLDLLLEA | 66 | Q27J81 | |
| LESLLQSIGEVEQNL | 4121 | Q9UPN3 | |
| ALELLASNIIDAQNS | 86 | Q86XN7 | |
| QNLLINELGAIKLAD | 131 | Q00526 | |
| DLSNIFLEGIAILNI | 646 | P49619 | |
| TNLGDLQFLAIDLVI | 956 | Q9NQ11 | |
| GEEEELNASQLQALL | 561 | Q6ZSI9 | |
| LLFSGNIQEAEIVLL | 666 | Q9P2H3 | |
| NIQEAEIVLLQAGLV | 671 | Q9P2H3 | |
| NVQSLLEAADLLQFL | 106 | Q8NBE8 | |
| IDGNLATEANLIILD | 1471 | Q96N67 | |
| LAIQQLAEGLTADDL | 156 | Q8IVS8 | |
| LENQLALLQDLPSTA | 91 | A6NNT2 | |
| EQFLVLINDLLASGE | 2866 | Q9UFH2 | |
| NNLLLDENGVLKLAD | 141 | P50613 | |
| LNSNNALIEFLLEGT | 661 | Q96JB2 | |
| QSKLAGLLDLNNAIL | 336 | P62508 | |
| EALALDKVGLNQQLL | 606 | Q9BV73 | |
| ILENSLLNLENGEDA | 416 | Q9BYX4 | |
| LLNLENGEDAGVQLS | 421 | Q9BYX4 | |
| NQGTLLSLSEQELLD | 311 | Q9UBX1 | |
| VLVLLLQNSVLAEDG | 11 | Q96P44 | |
| GQELAQAVLQLLAVE | 461 | Q6V0L0 | |
| LLLNNLGETFDLQLG | 1021 | Q6IMN6 | |
| DLNQLVTLELEGNNL | 436 | O94769 | |
| GLENLDTLLLQENSL | 186 | P07359 | |
| TSLLSIINDLLEQLG | 1511 | P11047 | |
| IINDLLEQLGQLDTV | 1516 | P11047 | |
| ESGLLSVLQIAQQDL | 111 | Q9HB96 | |
| KALQALENSDGLILN | 1561 | Q8NDH2 | |
| LGDQGNLSELVNLIL | 161 | Q5T7M9 | |
| NLSELVNLILTVADG | 166 | Q5T7M9 | |
| ILQALDAGLVVQLQA | 221 | Q9UPN6 | |
| DAGLVVQLQALTAQL | 226 | Q9UPN6 | |
| IAQLNDLDLGIGQII | 381 | P43005 | |
| LSLNGDLLAQEAQFV | 296 | Q8N309 | |
| RLNGLEISILAENLN | 656 | Q14114 | |
| SILNDNINLLGKVEL | 346 | Q03933 | |
| QRALQLALDQLSLLG | 31 | Q6ZN04 | |
| SLNLQSLNLDIQALA | 521 | Q92570 | |
| FLQALELLIGSLEQA | 401 | Q96C03 | |
| LCAEGFLLNNNLLTI | 846 | Q13423 | |
| FLLNNNLLTIVGALI | 851 | Q13423 | |
| GNLVNFLEDDTINLL | 56 | Q8TC99 | |
| DLIGQVVLDNLLELA | 396 | Q9BQG1 | |
| VLDQLQSLTQIDLEG | 516 | Q8IW52 | |
| EVQVNLSLLGDDLLL | 896 | Q2M3C7 | |
| LRLQLEVSQLEGSLQ | 831 | Q9UPR3 | |
| SQNEVELGELLLSLN | 316 | Q9BSW7 | |
| AQRLSAELLLGQLNA | 81 | Q15750 | |
| IDVLLLGNTLNSDLA | 476 | O43426 | |
| DASGLIAEQLLQQAA | 651 | Q9UFD9 | |
| NLLAQISALALQLDS | 2416 | Q5UIP0 | |
| NGNISVDDLIALLDL | 1141 | Q5K651 | |
| ALLNQALESNDLVSV | 376 | Q13576 | |
| DLLAVVQLSLQADLS | 1241 | Q6ZNJ1 | |
| QLLEAGIIDQQLLDQ | 891 | P58107 | |
| LQQDVTDGVLLAQII | 111 | Q8IVL1 | |
| LLEVGTFNALVELLN | 176 | Q5VSL9 | |
| IALFNQELVSGSELL | 331 | O75182 | |
| SQALVLGQLLGEQES | 781 | Q8TF17 | |
| SEALLAQAALLLQAA | 391 | Q2NL68 | |
| GLDQLIQRLLQSADE | 416 | O75570 | |
| TLAGLVVQLLQFQED | 76 | Q92922 | |
| AQLLLVNLLTFGLEV | 16 | Q96JT2 | |
| AFLVAEQELGIAQLL | 241 | Q9NRC6 | |
| GNQIEDDLLIQALTV | 41 | Q6Q759 | |
| LDLIAALALQALAEQ | 366 | Q96A09 | |
| GNLSLLEQAIALQAE | 301 | O60284 | |
| LIQNLSLLLVDASVG | 716 | Q15021 | |
| GLLEQAVATLQTLDL | 341 | Q5VXH5 | |
| LLNLQESGLLCEVEA | 366 | O94827 | |
| SLLLLNQCLEELQGV | 811 | Q14690 | |
| ILLDNTGNLAQAEAV | 626 | Q5T4D3 | |
| DEGAILAANLATVLQ | 401 | Q4W5G0 | |
| FQNNGVALLLQLLDT | 176 | Q8IWX7 | |
| QQDSQELLAFLLDGL | 391 | Q13107 | |
| DQLAGLQQELAALAL | 416 | Q9UH99 | |
| LILLDLGNNNIATVE | 401 | Q96PX8 | |
| LLDLSSNQLIDENQL | 256 | Q15813 | |
| LGLLSNVNRNAAVEL | 271 | P84022 | |
| IQAQGLEELTFNLLR | 361 | A2RTY3 | |
| QEQDIDGQALLLLTL | 846 | Q5VUG0 | |
| LVLGILLQDFRDQNI | 186 | Q5BVD1 | |
| ELIANGTLNILEEEN | 96 | Q9HAV4 | |
| INVESLLDGLNSLVL | 41 | O75116 | |
| ILDGSLGNIDDLAQQ | 51 | O94885 | |
| GEQINNIGLLDNLLF | 216 | P19634 | |
| NLAADLGLTALILDQ | 786 | O95359 | |
| LGLTALILDQDQQGI | 791 | O95359 | |
| LDLDQGLCNSQLVLE | 156 | O15040 | |
| SLNGVLVSQQNLLLE | 116 | A8MT19 | |
| LLGEVSQLQAFLQDL | 1056 | P11277 | |
| LSGLSLQEAQQILNV | 51 | Q9Y3D7 | |
| LLLQGEADQSLLTFI | 3051 | P78527 | |
| ELDFNLQALLEQLSQ | 6 | Q56P42 | |
| ISLLLEAGANVDAQN | 241 | Q8IUH5 | |
| EQILELLVLEQFLGA | 86 | P10073 | |
| LQEGDLILQINGVSS | 231 | O95049 | |
| GQDLLAQLEAANSLT | 571 | P98168 | |
| QAQAEDLSAQLALII | 976 | Q9Y4G6 | |
| LALEDTLQLCQAALG | 641 | Q8TF50 | |
| IFLDQEIDGQALLLL | 816 | Q9UHJ3 | |
| AGLSLVQLNELLEDE | 11 | Q9H9H4 | |
| EAIQLDGEILFSLLQ | 236 | Q9BXI6 | |
| CQEIGVSLNELLNLN | 1966 | O60293 | |
| QLQQVELALGAGLDS | 16 | Q8N5A5 | |
| QQDSQELLAFLLDGL | 621 | P35125 | |
| QLQEELLGIAQINLA | 696 | Q9ULE0 | |
| LSEELQGLDQLQLDN | 261 | P22415 | |
| ELQVQLSGDLTLGAQ | 1626 | Q5THJ4 | |
| QEVLAGVSSQLLNDL | 21 | Q86YQ2 | |
| LQLLDLSANQLEALA | 121 | Q2I0M4 | |
| TLLLNNLENAIALDF | 461 | O75096 | |
| AANQLLIIVDAGLED | 746 | O94898 | |
| VNLNLLGNELDTDGV | 1011 | Q86W25 | |
| LNLSTNNLLDDGVQL | 791 | Q86W24 |